THE EFFECTS OF TOPICAL DORZOLAMIDE HYDROCHLORIDE-TIMOLOL MALEATE OPHTHALMIC SOLUTION ON INJECTION FREQUENCY IN PATIENTS RECEIVING COMBINATION THERAPY FOR RETINAL VEIN OCCLUSIONS